Identifies themes and clusters of stock movements
Market TodayThemes and Stocks AnalysesThematic Stock SearchClick here for daily refresh schedule
CRON - Cronos Group, Inc.
$7.34
0.12(1.66%)9:00:00 PM 11/23/2020
Cronos Group, Inc. engages in the production and distribution of cannabis. Its brands include PEACE NATURALS, COVE, Spinach, Lord Jones and PEACE+. The company was founded by Lorne Michael Gertner and Paul Rosen on August 21, 2012 and is headquartered in Toronto, Canada.
Stock Chart
No summary

Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from 

Finra

Moving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.

Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.

Related Topics

Stock news

    11/23/2020CRON
    IIPR, IBD Stock Of The Day, Offers Multiple Entries As Marijuana Stocks Shape Up

    Innovative Industrial Properties is the IBD Stock of the Day. IIPR stock has been trading tightly over the past few weeks.

    11/22/2020CRON
    3 Top Canadian Pot Stocks For Your Portfolio

    Marijuana is legal across Canada, and sales are soaring. These businesses are a great way to get into this exploding industry.

    11/22/2020CRON
    Better Marijuana Stock to Buy: Cronos or Canopy Growth?

    Cronos Group (NASDAQ: CRON) and Canopy Growth (NYSE: CGC) are two marijuana companies that have been around since Canada first legalized medicinal marijuana in 2013. Now that pot legalization is picking up steam in the U.S. as well, marijuana investors are wondering whether the two mavericks can replicate the successes of their premium pot brands down south. Today, let's look at which of these two high-flying marijuana stocks is the better fit for investors' portfolios.

    11/20/2020CRON
    Why the Bull Run in Canopy Growth Will Last

    Since early 2019, Canopy Growth (NASDAQ:CGC) has suffered a grueling bear move. During this period, CGC stock has gone from $50 to just under $24. The market capitalization is now at $8.9 billion. Source: Shutterstock Of course, the whole industry has been under pressure. Just look at the poor performances of stocks like Tilray (NASDAQ:TLRY), Aurora Cannabis (NYSE:ACB), Cronos (NASDAQ:CRON), and Aphria (NASDAQ:APHA). They have all lost significant amounts of their values. There have certainly ...

    11/19/2020CRON
    Is This The Best Way To Play The Second Boom In Marijuana?

    Hopes of nationwide legalization have triggered another rally in cannabis shares, and this time it’s all about big data, science and boosting market share

    11/18/2020CRON
    Too high? Hedge funds unimpressed by Canadian cannabis stocks' rally

    "I wouldn't recommend investing in Canadian cannabis companies because they have a cost disadvantage versus other operators," said George Schultze, founder at Schultze Asset, who has exposure to the sector. Cronos Group saw the number of short trades as a percentage of its total traded volume fall slightly to approximately 26.7% for the first half of November, from 28% for the second half of October, regulatory filings showed.

    11/13/2020CRON
    Cronos Group Inc. to Present at the Jefferies Virtual West Coast Consumer Conference

    TORONTO, Nov. 13, 2020 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”), an innovative global cannabinoid company, today announced that Mike Gorenstein, Executive Chairman, will speak at the Jefferies Virtual West Coast Consumer Conference on Tuesday, November 17, 2020 at 1:10 p.m. EST. The webcast will be available on the Investors section of the Company’s website at ir.thecronosgroup.com/events-presentations.About Cronos Group Inc. Cronos Gro...

    11/10/2020CRON
    Should You Buy Marijuana Stocks After The 2020 Election?

    Are marijuana stocks a good buy amid the coronavirus pandemic? The marijuana industry gets lots of hype, but pot stocks have poor fundamentals and technicals.